Browsing Awaiting Allocation by Subject "Immunosuppressive Agents"
Now showing items 1-1 of 1
-
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.
(2022-10)BACKGROUND: Interferon-β, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS. RESULTS: Among 5,568 patients (83.4% confirmed COVID-19), interferon-treated patients had ...